Fasidotril: The First Dual Inhibitor of Neprilysin and ACE

This publication has 36 references indexed in Scilit:

• Section Review: Cardiovascular & Renal: Recent advances in the development of dual angiotensin-converting enzyme and neutral endopeptidase inhibitors
  Expert Opinion on Therapeutic Patents, 1996
• New Dual Inhibitors of Neutral Endopeptidase and Angiotensin-Converting Enzyme: Rational Design, Bioavailability, and Pharmacological Responses in Experimental Hypertension
  Journal of Medicinal Chemistry, 1994
• Candoxatril, a neutral endopeptidase inhibitor
  Journal Of Hypertension, 1992
• Attenuated renal excretory response to atrial natriuretic peptide in congestive heart failure in man
  International Journal of Cardiology, 1991
• Role of endogenous atrial natriuretic peptide in regulating sodium excretion in spontaneously hypertensive rats. Effects of neutral endopeptidase inhibition.
  Hypertension, 1991
• Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11): rational design, properties, and potential cardiovascular applications of glycopril and alatriopril.
  Proceedings of the National Academy of Sciences, 1991
• Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure.
  Circulation, 1990
• Effect of sinorphan on plasma atrial natriuretic factor in congestive heart failure
  The Lancet, 1990
• Effect of converting enzyme inhibition on renin synthesis and secretion in mice.
  Hypertension, 1989
• An Intramolecularly Quenched Fluorescent Tripeptide as a Fluorogenic Substrate of Angiotensin‐I‐Converting Enzyme and of Bacterial Dipeptidyl Carboxypeptidase
  European Journal of Biochemistry, 1978